Black Rock Inc. Akero Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,586,637 shares of AKRO stock, worth $288 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,586,637
Previous 4,892,616
14.19%
Holding current value
$288 Million
Previous $124 Million
6.05%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AKRO
# of Institutions
268Shares Held
86MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$382 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$364 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$306 Million0.05% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$270 Million7.15% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.82MShares$248 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.39B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...